We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Machine Learning Tools for COVID-19 Patient Screening Discussed at AACC 2021

By LabMedica International staff writers
Posted on 29 Sep 2021

A team of researchers at the National Institute of Blood Disease (Karachi, Pakistan) have created a new machine learning tool that could help healthcare workers to quickly screen and direct the flow of COVID-19 patients arriving at hospitals. More...

The results from an evaluation of this algorithm were presented at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.

It is important for clinicians to quickly diagnose COVID-19 patients when they arrive at hospitals, both to triage them and to separate them from other vulnerable patients who may be immunocompromised or have pre-existing medical conditions. This can be difficult, however, because COVID-19 shares many symptoms with other viral infections, and the most accurate PCR-based tests for COVID-19 can take several days to yield results.

This led the researchers to create a machine learning algorithm to help healthcare workers efficiently screen incoming COVID-19 patients. The scientists extracted routine diagnostic and demographic data from the records of 21,672 patients presenting at hospitals and applied several statistical techniques to develop this algorithm, which is a predictive model that differentiates between COVID-19 and non-COVID-19 patients. During validation experiments, the model performed with an accuracy of up to 92.5% when tested with an independent dataset and showed a negative predictive value of up to 96.9%. The latter means that the model is particularly reliable when identifying patients who don’t have COVID-19.

“The true negative labeling efficiency of our research advocates its utility as a screening test for rapid expulsion of SARS-CoV-2 from emergency departments, aiding prompt care decisions, directing patient-case flow, and fulfilling the role of a ‘pre-test’ concerning orderly RT-PCR testing where it is not handy,” said Dr. Rana Zeeshan Haider, PhD who led the study. “We propose this test to accept the challenge of critical diagnostic needs in resource constrained settings where molecular testing is not under the flag of routine testing panels.”

Related Links:
National Institute of Blood Disease 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
AGGRENG-40
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








ADLM

Channels

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.